GlassScriptPhysician profile
Robert A Briskin
NPI 1326004680
$499.36
in general payments reported to CMS, 2019-2025
13 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.49 · 2020: $11.77 · 2023: $142 · 2024: $58.27 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425 · Education: $49.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.11 |
| Education | $49.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $98.66 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $59.41 | 2025 | |
| Glaxosmithkline, LLC. | $56.39 | 2023 | Trelegy Ellipta, Shingrix |
| Janssen Biotech, INC. | $49.99 | 2025 | Tecvayli, Talvey, Darzalex |
| Otsuka America Pharmaceutical, INC. | $44.52 | 2025 | Rexulti |
| Exact Sciences Corporation | $39.61 | 2024-2025 | Cologuard Collection Kit |
| Regeneron Healthcare Solutions, INC. | $37.04 | 2025 | Libtayo |
| Xeris Pharmaceuticals, INC. | $24.93 | 2025 | Keveyis |
| Boston Scientific Corporation | $23.81 | 2023 | |
| Merck Sharp & Dohme LLC | $21.56 | 2025 | Capvaxive |
| Lilly USA, LLC | $19.18 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.49 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Briskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.